The debt of IMMUNITYBIO, INC. over the past 10 years
Chart IMMUNITYBIO, INC.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, IMMUNITYBIO, INC. had liquid cash of $242.82M and total debt of $801.71M: net debt of $558.89M. It had more liquid cash than debt at 3 of the 9 year-ends shown. Total debt was highest at the end of fiscal 2023 ($836.95M) and lowest at the end of fiscal 2016 ($0). No net cash figure is on file for fiscal 2019.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $242.82M* | $801.71M | -$558.89M |
| 2024ended Dec 31, 2024 | $149.81M* | $746.28M | -$596.47M |
| 2023ended Dec 31, 2023 | $266.46M* | $836.95M | -$570.49M |
| 2022ended Dec 31, 2022 | $107.18M* | $673.17M | -$565.99M |
| 2021ended Dec 31, 2021 | $317.12M* | $605.59M | -$288.47M |
| 2020ended Dec 31, 2020 | $96.06M* | $254.35M | -$158.29M |
| 2019ended Dec 31, 2019 | $51.65M* | — | — |
| 2018ended Dec 31, 2018 | $74.87M* | $0 | $74.87M |
| 2017ended Dec 31, 2017 | $128.15M* | $0 | $128.15M |
| 2016ended Dec 31, 2016 | $198.92M* | $0 | $198.92M |
Fiscal years as IMMUNITYBIO, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on IMMUNITYBIO, INC.
- The revenue of IMMUNITYBIO, INC.
- The profitability of IMMUNITYBIO, INC.
- The cash flow of IMMUNITYBIO, INC.
- All of IMMUNITYBIO, INC.'s financials, charted
Companies of a similar size
- BRXBrixmor Property Group Inc.
- TTMITTM TECHNOLOGIES, INC.
- REXRRexford Industrial Realty, Inc.
- DBXDropbox, Inc.
- ZETAZeta Global Holdings Corp.
Not investment advice. This page shows what IMMUNITYBIO, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.